Systems and methods for delivery of a therapeutic agent
Methods and apparatus are provided for applying an fragment of a neurotoxin such as the active light chain (LC) of the botulinum toxin (BoNT), such as one of the serotype A, B, C, D, E, F or G botulinum toxins, via permeabilization of targeted cell membranes to enable translocation of the botulinum neurotoxin light chain (BoNT-LC) molecule across the targeted cell membrane to the cell cytosol where a therapeutic response is produced in a mammalian system. The methods and apparatus include use of catheter based delivery systems, non-invasive delivery systems, and transdermal delivery systems.
1. A device for altering function of a bronchial airway of a patient by controlling mucus secretion, the device comprising:
a main catheter body configured to extend though a trachea into the bronchial airway; and
at least one energy applicator having at least one energy emitter configured to emit energy relative to the main catheter body,
wherein the device is adapted to deliver energy from the at least one energy emitter to produce an energy field concentrated in a target region in a wall of the bronchial airway in a first lateral direction from the catheter body to alter cells within the target region.
2. The device of claim 1 , wherein the energy is at least one of x-ray energy, radiofrequency energy, DC current, AC current, microwave energy, and ultrasound energy.
3. The device of claim 1 , wherein the at least one energy emitter comprises at least one electrode, and the energy is RF energy.
4. The device of claim 1 , wherein the at least one energy emitter comprises at least one ultrasound transducer, and the energy is ultrasound energy.
5. The device of claim 1 , wherein the device is adapted to electroporate cells within the target region.
6. The device of claim 5 , wherein the device is further configured to deliver a neurotoxin to the electroporated cells in the target region.
7. The device of claim 1 , further comprising a movable mechanism to move the at least one energy applicator laterally within the bronchial airway, wherein the movable mechanism comprises an expandable member coupled to the main catheter body, the expandable member being configured to expand to move the at least one energy emitter into contact with or in apposition with the first portion of the airway wall.
8. The device of claim 7 , wherein the expandable member is further configured to expand such that the expandable member engages a second portion of the airway wall.
9. The device of claim 1 , wherein the target region comprises a mucosal lining of the lung, cholinergic cells in the region of tumors, myofacial regions, vascular smooth muscle cells, musculoskeletal regions, or combinations thereof.
10. A system for altering function of a bronchial airway of a patient by controlling mucus secretion, the system comprising:
an intraluminal catheter configured to be positioned within a bronchial airway of a patient, the intraluminal catheter including
a main catheter body, and
a first energy emitter configured to emit energy laterally relative to the main catheter body;
a movable mechanism coupled to a distal end of the main catheter body, and configured to move the first energy emitter laterally within the bronchial airway; and
an energy generator operably coupled to the first energy emitter and configured to activate the first energy emitter, thereby causing an energy field to be generated in a target region in the airway wall to alter cells within the target region.
11. The system of claim 10 , wherein the first energy emitter is coupled to the movable mechanism, the system further comprising:
a second energy emitter operably coupled to the energy generator, the second energy emitter being configured to be positioned outside of the airway and remote from the target region, the target region being positioned between the first and second energy emitters such that activation of the first and second energy emitters by the energy generator produces the energy field between the first and second emitters and within the target region.
12. The system of claim 11 , wherein a placement of the first and second energy emitters relative to each other controls the size and/or intensity of the energy field.
13. The system of claim 10 , the system further comprising:
a second energy emitter operably coupled to the energy generator, and coupled to the movable mechanism relative to the first energy emitter such that an arrangement of the first and second energy emitters causes the energy field produced therefrom to be concentrated in a lateral direction from the main catheter body.
14. The system of claim 10 , a second energy emitter operably coupled to the energy generator, and coupled to the movable mechanism relative to the first energy emitter such that an arrangement of the first and second energy emitters causes the energy field produced therefrom to comprise a uniform energy field about the main catheter body.
15. The system of claim 10 , wherein the movable mechanism comprises an expandable member coupled to the main catheter body, the expandable member being configured to expand to move the first energy emitter into contact with a first portion of the airway wall.
16. The system of claim 15 , wherein the expandable member is further configured to expand such that the expandable member engages a second portion of the airway wall.
17. The system of claim 10 , wherein the energy is at least one of x-ray energy, radiofrequency energy, DC current, AC current, microwave energy, and ultrasound energy.
18. The system of claim 10 , wherein the first energy emitter comprises an electrode, and the energy is RF energy.
19. The system of claim 18 , wherein the energy is RF energy.
20. The system of claim 10 , wherein the first energy emitter comprises an ultrasound transducer, and the energy is ultrasound energy.